Skip Navigation

Neuro-Oncology 2005 7(2):154-163; doi:10.1215/S1152851704000547
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lorente, G.
Right arrow Articles by Foehr, E. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lorente, G.
Right arrow Articles by Foehr, E. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 by the Society forNeuro-Oncology

Functional comparison of long and short splice forms of RPTPβ:Implications for glioblastoma treatment

Gustavo Lorente, April Nelson, Sabine Mueller, Jane Kuo, Roman Urfer, Karoly Nikolich and Erik D. Foehr1

AGY Therapeutics, Inc., 270 East Grand Avenue, South San Francisco,CA 94080, USA

1 Address correspondence to Erik D. Foehr, AGY Therapeutics, Inc., 270 EastGrand Avenue, South San Francisco, CA 94080, USA(efoehr{at}agyinc.com).


   Abstract

The receptor protein tyrosine phosphatase beta (RPTPβ PTP{xi}) isoverexpressed in glioblastoma tumors and plays a functional role in tumor cellmigration and adhesion. Glioblastomas express at least three splice variantsof RPTPβ, including long and short receptor forms and a secretedchondroitin sulfate proteoglycan called phosphacan. Here we explore thedifferences in the expression pattern and function of long RPTPβ andshort RPTPβ. The short form of RPTPβ lacks exon 12, which encodes860 amino acids located in the extracellular domain. Until now, functionaldifferences between long and short RPTPβ have been difficult toelucidate. In this study, antibodies specific to the splice junction, uniqueto short RPTPβ, allowed for the discrimination of the two receptors. Astudy of normal brain tissue and graded astrocytomas indicates that long andshort RPTPβ forms have an overlapping expression pattern. In order tostudy functional differences between long and short RPTPβ, we createdstable U87 glioblastoma cells that expressed these receptors. U87 stable celllines overexpressing long or short RPTPβ migrate faster and adhere morerobustly than parental U87 cells. The two forms differ in thatlong-RPTPβ-overexpressing cells migrate and adhere better thanshort-RPTPβ-overexpressing cells. A study of the extracellular domain ofshort RPTPβ indicates that it retains much of the functional capacity ofphosphacan. Indeed, the action of recombinant, short-RPTPβ extracellulardomain protein is similar to that of phosphacan as a repulsive substrate forglioblastoma cells. Comparison of the signaling capacity of long RPTPβ tothat of short RPTPβ reveals very similar abilities to activatetranscription pathways. Moreover, transient transfection with either long orshort RPTPβ activates NF-{kappa}B reporter gene transcription. Because oftheir tumor-restricted and largely overlapping expression patterns inglioblastoma, both RPTPβ splice forms are potential therapeutic targets.The involvement of long and short RPTPβ in glioma tumor cell biology alsocontributes to the value of RPTPβ as a cancer target.

Received May 27, 2004; Accepted November 2, 2004


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.